Evidence map›Paper›PMID 41599117›Full record

ArticlePharmaceutics2025

The Impact of Vehicle Occlusivity on Skin Delivery and Activity of a Janus Kinase Inhibitor: Comparison of Oil-Based Formulations.

Paulo Sarango-Granda, Roya Mohammadi-Meyabadi, Antonio J Braza, Lilian Sosa, Joaquim Suñer-Carbó, Mireia Mallandrich, Ana Cristina Calpena

Abstract read
In one paragraph

Article in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Paulo Sarango-GrandaDepartamento de Química, Facultad de Ciencias Exactas y Naturales, Universidad Técnica Particular de Loja (UTPL), Paris SN y Praga, Loja 1101607, Ecuador.ORCID 0000-0001-9178-635X
Roya Mohammadi-MeyabadiDepartament de Farmàcia i Tecnologia Farmacèutica, i Fisicoquímica, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona (UB), Av. Joan XXIII, 27-31, 08028 Barcelona, Spain.ORCID 0000-0003-4799-6362
Antonio J BrazaDepartament de Farmàcia i Tecnologia Farmacèutica, i Fisicoquímica, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona (UB), Av. Joan XXIII, 27-31, 08028 Barcelona, Spain.ORCID 0009-0009-2669-7006
Lilian SosaInstituto de Investigaciones en Microbiología (IIM), Facultad de Ciencias, Universidad Nacional Autónoma de Honduras (UNAH), Tegucigalpa 11101, Honduras.ORCID 0000-0001-8148-9482
Joaquim Suñer-CarbóDepartament de Farmàcia i Tecnologia Farmacèutica, i Fisicoquímica, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona (UB), Av. Joan XXIII, 27-31, 08028 Barcelona, Spain.ORCID 0000-0002-9238-187X
Mireia MallandrichDepartament de Farmàcia i Tecnologia Farmacèutica, i Fisicoquímica, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona (UB), Av. Joan XXIII, 27-31, 08028 Barcelona, Spain.ORCID 0000-0001-9316-8459
Ana Cristina CalpenaDepartament de Farmàcia i Tecnologia Farmacèutica, i Fisicoquímica, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona (UB), Av. Joan XXIII, 27-31, 08028 Barcelona, Spain.ORCID 0000-0002-4989-4821

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

JAK1/JAK 2 inhibitorlipid formulationsmedium-chain triglycerides (MCT)occlusivitypetrolatumtopical deliverytopical excipients

Identifiers

PMID41599117
PMCPMC12844953

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.